Related Experiment Videos
Toxic megacolon associated with anticancer chemotherapy
C J de Gara1, N Gagic, A Arnold
1Department of Surgery, Henderson General Hospital, Hamilton, Ont.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|August 1, 1991
Summary
Anticancer chemotherapy can cause severe gastrointestinal issues, including toxic megacolon. This rare but dangerous complication, often linked to ulcerative colitis, requires careful monitoring in patients undergoing cancer treatment.
Area of Science:
- Gastroenterology
- Oncology
- Internal Medicine
Background:
- Gastrointestinal (GI) side effects are common during anticancer chemotherapy.
- Most chemotherapy-induced GI toxicities are mild and manageable.
- Severe complications like necrotizing enterocolitis and ischemic colitis can occur.
Observation:
- This case report details a patient experiencing toxic megacolon.
- Toxic megacolon developed in the context of anticancer chemotherapy.
- The patient had a history of ulcerative colitis.
Findings:
- Anticancer chemotherapy can precipitate toxic megacolon.
- Toxic megacolon is a rare but serious adverse event.
- This complication is particularly relevant in patients with pre-existing ulcerative colitis.
Implications:
- Clinicians should be aware of toxic megacolon as a potential chemotherapy complication.
- Early recognition and management are crucial for improving patient outcomes.
- Further research may elucidate the mechanisms linking chemotherapy and toxic megacolon in ulcerative colitis patients.